Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Head and Neck Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Oropharyngeal Neoplasms 3 Carcinoma, Squamous Cell 2 Tongue Neoplasms 1 Thyroid Neoplasms 1 Pain, Postoperative 1 Neoplasms 1 Neoplasm Metastasis 1 Mouth Neoplasms 1 Carcinoma, Medullary 1 Carcinoma 1

Interventions

Cisplatin 21 pembrolizumab 16 Gemcitabine 16 Paclitaxel 15 Radiotherapy 14 Carboplatin 14 Radiotherapy, Intensity-Modulated 13 Cyclophosphamide 9 Cetuximab 9 Magnetic Resonance Spectroscopy 8 Radiation 7 padeliporfin 6 Specimen Handling 6 Oxaliplatin 6 Fluorouracil 6 Drug Therapy 6 Docetaxel 6 Capecitabine 6 Bevacizumab 6 anlotinib 5 Nivolumab 5 Irinotecan 5 Erlotinib Hydrochloride 5 Celecoxib 5 poly ICLC 4 fludarabine 4 Standard of Care 4 Sorafenib 4 Leucovorin 4 Ipilimumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma × Neck Dissection × Clear all

NCT05144100 2021-12-03

SCOPE

Tata Memorial Centre

Phase 2/3 Not yet recruiting

Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡